Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Continuous Monitoring of Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage (BP-MONICH)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2013 by Azienda Ospedaliera Sant'Anna.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Simone Vidale, Azienda Ospedaliera Sant'Anna
ClinicalTrials.gov Identifier:
NCT01956292
First received: September 29, 2013
Last updated: October 5, 2013
Last verified: October 2013
  Purpose
Evaluation of blood pressure variability in the acute phase of intraparenchimal cerebral haemorrhage and its consequences to clinical outcome

Condition
Intraparenchimal Cerebral Haemorrhage

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Observational Study of Continous Monitoring of Arterial Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage

Resource links provided by NLM:


Further study details as provided by Azienda Ospedaliera Sant'Anna:

Primary Outcome Measures:
  • evaluation of blood pressure varibility on clinical course in patients with cerebral haemorrhage [ Time Frame: Day 7 ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: October 2013
Estimated Study Completion Date: June 2015
Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Intraparenchimal cerebral haemorrhage

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients admitted to hospital for intraparenchimal cerebral haemorrhage
Criteria

Inclusion Criteria:

  • hospitalization only for spontaneous intraparenchimal cerebral haemorrhage
  • age over 18 years

Exclusion Criteria:

  • cerebral haemorrhage secondary to other causes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01956292

Locations
Italy
AO Sant'Anna Hospital
Como, Italy, 22100
Sponsors and Collaborators
Azienda Ospedaliera Sant'Anna
  More Information

Responsible Party: Simone Vidale, M.D., Azienda Ospedaliera Sant'Anna
ClinicalTrials.gov Identifier: NCT01956292     History of Changes
Other Study ID Numbers: OSA-0002 
Study First Received: September 29, 2013
Last Updated: October 5, 2013
Health Authority: Italy: The Italian Medicines Agency

Additional relevant MeSH terms:
Hemorrhage
Cerebral Hemorrhage
Pathologic Processes
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on December 09, 2016